RATIONALE: Cellular sex differences remain largely unexplored in asthma. Type 2 innate lymphoid cells (ILC2s), identified as critical modulators of asthmatic inflammation, are less abundant in the lungs of HDM-sensitized and challenged male mice. Specifically, lung ILC2s numbers increase in the absence of androgen signaling, but not estrogen. Therefore, we hypothesize that female asthmatics have increased airway ILC2s compared to males. METHODS: In a retrospective study of adult, non-smoker, dualresponder mild asthmatics (MA) (8 male, 11 female; FEV 1 > _80% predicted, methacholine PC 20 < _16mg/ml, intermittent b2 agonist) and prednisonedependent, severe asthmatics (SA) (13 male, 17 female; FEV 1 <80% predicted, methacholine PC 20 < _8mg/ml, sputum eosinophilia>3%, ICS/ LABA>880mg/day; prednisone> _7.5mg/day), sputum and blood ILC2s (lin-FcεRI-CD45+CD127+CRTH2+ and intracellular IL-5+IL13+) were enumerated by flow cytometry at baseline (MA and SA) and post-allergen challenge (MA only). RESULTS: Spirometry, methacholine PC 20 and sputum eosinophilia in each group were comparable between sexes at baseline. At baseline, MA females had significantly more total sputum ILC2s than males but there were no significant differences in cytokine-producing ILC2s. At 24 hours post-allergen, there were no between-sex differences in lung function, airway eosinophilia, sputum extracted total or cytokine+ ILC2 levels. Amongst SA, there were no significant sex differences in total or cytokine-producing ILC2 in sputum or blood at baseline. Using a generalized linear model to account for age, ILC2 levels remained comparable between the sexes. Similar findings were observed for CD4+ T cells for all asthmatics. CONCLUSIONS: Major type 2 inflammatory cells, including ILC2 and CD4+ T cells in blood and sputum, from clinically similar asthmatics are comparable irrespective of sex. Hillary L. Shane, PhD, Ewa Lukomska, and Stacey Anderson, PhD; CDC/NIOSH, Morgantown, WV. RATIONALE: Didecyldimethylammonium chloride (DDAC) is an antimicrobial dialkyl-quaternary ammonium compound used in numerous products. Clinical data suggest that DDAC exposure elicits multiple types of hypersensitivity reactions; animal data supports a mixed-type response. Skin is a major route of exposure to chemicals; thus, we investigated immune responses in the skin to determine the mechanism behind DDACinduced sensitization. METHODS: BALB/C or Rag2 -/-mice (which lack T and B cells) were exposed topically on the ear to sensitizing concentrations of DDAC (0.25% and 0.5%) or acetone as the vehicle control for 7 days. In the skin, gene expression was analyzed by RT-qPCR, protein levels were analyzed by ELISA and Luminex assay, and cellular phenotyping was performed using flow cytometry. RESULTS: Skin Tslp, Ccl17, Il4, and Il33 increased in DDAC exposed animals, implicating type 2 innate lymphoid cell (ILC2) responses. Correspondingly, dermal ILC2s were activated 24 hours after DDAC exposure, assessed by increased levels of CD25, ICOS and KLRG1, and decreased CD127 expression throughout 7 days of exposure. Following ILC2 activation, the Th2 cytokine IL-4 was elevated compared to control mice in total ear protein lysate (0.5% DDAC). ILC2s from Rag2 -/-mice were similarly activated by DDAC, and produced significant levels of IL-4 and IL-5 in the skin (0.5% DDAC). CONCLUSIONS: Following DDAC exposure, skin ILC2s become activated and produce Th2 cytokines. Importantly, Th2 cytokine responses were not dampened in Rag2 -/-mice, emphasizing the contribution of ILC2s. The activation of ILC2s provides a possible mechanism for the development of the mixed-type allergic responses commonly observed with chemical sensitizers.
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